Osteonectin promoter-mediated suicide gene therapy of prostate cancer

Wan Chi Hsiao, Shian Ying Sung, Leland W.K. Chung, Chia Ling Hsieh

研究成果: 書貢獻/報告類型 › 章節

摘要

Suicide gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene, combined with the prodrug ganciclovir (GCV) medication, is a promising approach for the treatment of malignant tumors, including prostate cancer. The success of this therapeutic strategy requires tissue- or tumor-specific gene expression and efficient gene delivery. In this chapter, we describe the experimental protocols of key methodologies, including promoter construction, reporter assay, adenoviral vector construction and preparation, HSV-tk enzymatic assay and cytotoxicity assay to evaluate the specificity and efficacy of osteonectin promoter-mediated HSV-tk/GCV suicide gene therapy of prostate cancer.
原文英語
主出版物標題Methods in Molecular Biology
發行者Humana Press Inc.
頁面27-42
頁數16
DOIs
出版狀態已發佈 - 一月 1 2019

出版系列

名字Methods in Molecular Biology
卷1895
ISSN（列印）1064-3745

指紋

Osteonectin
Thymidine Kinase
Simplexvirus
Genetic Therapy
Suicide
Prostatic Neoplasms
Ganciclovir
Prodrugs
Enzyme Assays
Genes
Neoplasms
Gene Expression
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

引用此文

Hsiao, W. C., Sung, S. Y., Chung, L. W. K., & Hsieh, C. L. (2019). Osteonectin promoter-mediated suicide gene therapy of prostate cancer. 於 Methods in Molecular Biology (頁 27-42). (Methods in Molecular Biology; 卷 1895). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8922-5_3

Osteonectin promoter-mediated suicide gene therapy of prostate cancer. / Hsiao, Wan Chi; Sung, Shian Ying; Chung, Leland W.K.; Hsieh, Chia Ling.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 27-42 (Methods in Molecular Biology; 卷 1895).

研究成果: 書貢獻/報告類型 › 章節

Hsiao, WC, Sung, SY, Chung, LWK & Hsieh, CL 2019, Osteonectin promoter-mediated suicide gene therapy of prostate cancer. 於 Methods in Molecular Biology. Methods in Molecular Biology, 卷 1895, Humana Press Inc., 頁 27-42. https://doi.org/10.1007/978-1-4939-8922-5_3
Hsiao WC, Sung SY, Chung LWK, Hsieh CL. Osteonectin promoter-mediated suicide gene therapy of prostate cancer. 於 Methods in Molecular Biology. Humana Press Inc. 2019. p. 27-42. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-8922-5_3
Hsiao, Wan Chi ; Sung, Shian Ying ; Chung, Leland W.K. ; Hsieh, Chia Ling. / Osteonectin promoter-mediated suicide gene therapy of prostate cancer. Methods in Molecular Biology. Humana Press Inc., 2019. 頁 27-42 (Methods in Molecular Biology).
@inbook{d9805208ca15465f851137147ed4bc68,
title = "Osteonectin promoter-mediated suicide gene therapy of prostate cancer",
abstract = "Suicide gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene, combined with the prodrug ganciclovir (GCV) medication, is a promising approach for the treatment of malignant tumors, including prostate cancer. The success of this therapeutic strategy requires tissue- or tumor-specific gene expression and efficient gene delivery. In this chapter, we describe the experimental protocols of key methodologies, including promoter construction, reporter assay, adenoviral vector construction and preparation, HSV-tk enzymatic assay and cytotoxicity assay to evaluate the specificity and efficacy of osteonectin promoter-mediated HSV-tk/GCV suicide gene therapy of prostate cancer.",
keywords = "Adenoviral vector, HSV-tk enzymatic assay, Osteonectin promoter construction, Prostate cancer, Suicide gene therapy",
author = "Hsiao, {Wan Chi} and Sung, {Shian Ying} and Chung, {Leland W.K.} and Hsieh, {Chia Ling}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-8922-5_3",
language = "English",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "27--42",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Osteonectin promoter-mediated suicide gene therapy of prostate cancer

AU - Hsiao, Wan Chi

AU - Sung, Shian Ying

AU - Chung, Leland W.K.

AU - Hsieh, Chia Ling

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Suicide gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene, combined with the prodrug ganciclovir (GCV) medication, is a promising approach for the treatment of malignant tumors, including prostate cancer. The success of this therapeutic strategy requires tissue- or tumor-specific gene expression and efficient gene delivery. In this chapter, we describe the experimental protocols of key methodologies, including promoter construction, reporter assay, adenoviral vector construction and preparation, HSV-tk enzymatic assay and cytotoxicity assay to evaluate the specificity and efficacy of osteonectin promoter-mediated HSV-tk/GCV suicide gene therapy of prostate cancer.

AB - Suicide gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene, combined with the prodrug ganciclovir (GCV) medication, is a promising approach for the treatment of malignant tumors, including prostate cancer. The success of this therapeutic strategy requires tissue- or tumor-specific gene expression and efficient gene delivery. In this chapter, we describe the experimental protocols of key methodologies, including promoter construction, reporter assay, adenoviral vector construction and preparation, HSV-tk enzymatic assay and cytotoxicity assay to evaluate the specificity and efficacy of osteonectin promoter-mediated HSV-tk/GCV suicide gene therapy of prostate cancer.

KW - Adenoviral vector

KW - HSV-tk enzymatic assay

KW - Osteonectin promoter construction

KW - Prostate cancer

KW - Suicide gene therapy

UR - http://www.scopus.com/inward/record.url?scp=85058589961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058589961&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-8922-5_3

DO - 10.1007/978-1-4939-8922-5_3

M3 - Chapter

T3 - Methods in Molecular Biology

SP - 27

EP - 42

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -

存取文件